Repligen Corp.
Sector: Manufacturing
Industry: Pharmaceutical Products
123.24
-4.61
(-3.61%)
Volume:
580,990
52 week range:
102.97 - 182.52
Market Cap:
6.924B
Company Description:
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company sells its products to life sciences, biopharmaceutical companies; laboratory researchers; and contract manufacturing organizations.